This week, I began a three-month course of Ozempic, the wonder drug touted to reduce cardiovascular risk for the overweight and those with diabetes.
Ozempic journey
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
